RNA Q1 2024 Earnings — Avidity Biosciences, Inc. Revenue & Financial Results | Market Cap Arena

RNAAvidity Biosciences, Inc.

$2B

Q1 2024 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$4M+58.7% YoY

Gross Profit

$3M81.9% margin

Operating Income

-$77M-2178.6% margin

Net Income

-$69M-1943.4% margin

EPS (Diluted)

$-0.79

QoQ Revenue Growth

+61.6%

Cash Flow

Operating Cash Flow

-$70M

Free Cash Flow

-$71M

Stock-Based Comp.

$10M

Balance Sheet

Total Assets

$951M

Total Liabilities

$121M

Stockholders' Equity

$831M

Cash & Equivalents

$471M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$4M	$2M	+58.7%
Gross Profit	$3M	-$46M	+106.4%
Operating Income	-$77M	-$58M	-34.0%
Net Income	-$69M	-$52M	-31.4%